Tyrosine kinase inhibitors may change the metastatic pattern. [electronic resource]
- Journal of B.U.ON. : official journal of the Balkan Union of Oncology
- 544 p. digital
Publication Type: Case Reports; Letter
1107-0625
Adenocarcinoma--drug therapy Adenocarcinoma of Lung Antineoplastic Agents--therapeutic use ErbB Receptors--antagonists & inhibitors Erlotinib Hydrochloride Female Humans Lung Neoplasms--drug therapy Middle Aged Protein Kinase Inhibitors--therapeutic use Quinazolines--therapeutic use Skin Neoplasms--secondary Treatment Outcome